Matteo Ferrari Email

Postdoctoral Research Fellow . DIOSynVax

Current Roles

Employees:
23
Revenue:
$3.6M
About
DIOSVax is a biotech startup working to revolutionise the way humanity protects itself from infectious disease and emerging pathogens. The company is named after its core technology, DIOSynVax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines), a new system that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
DIOSynVax Address
25 Sedley Taylor Rd
Cambridge, null
DIOSynVax Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.